BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16554441)

  • 1. A novel function of OLIG2 to suppress human glial tumor cell growth via p27Kip1 transactivation.
    Tabu K; Ohnishi A; Sunden Y; Suzuki T; Tsuda M; Tanaka S; Sakai T; Nagashima K; Sawa H
    J Cell Sci; 2006 Apr; 119(Pt 7):1433-41. PubMed ID: 16554441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA.
    Tabu K; Ohba Y; Suzuki T; Makino Y; Kimura T; Ohnishi A; Sakai M; Watanabe T; Tanaka S; Sawa H
    Mol Cancer Res; 2007 Oct; 5(10):1099-109. PubMed ID: 17951409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).
    Williamson EA; Wolf I; O'Kelly J; Bose S; Tanosaki S; Koeffler HP
    Oncogene; 2006 Mar; 25(9):1391-9. PubMed ID: 16331276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mechanism of transcriptional repression of p27kip1 through Notch/HRT2 signaling in vascular smooth muscle cells.
    Havrda MC; Johnson MJ; O'Neill CF; Liaw L
    Thromb Haemost; 2006 Sep; 96(3):361-70. PubMed ID: 16953280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of telomerase activity in malignant glioma cells by p27KIP1.
    Kanzawa T; Komata T; Kyo S; Germano IM; Kondo Y; Kondo S
    Int J Oncol; 2003 Dec; 23(6):1703-8. PubMed ID: 14612944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1.
    Cen B; Deguchi A; Weinstein IB
    Cancer Res; 2008 Jul; 68(13):5355-62. PubMed ID: 18593937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kip1).
    Williamson EA; Dadmanesh F; Koeffler HP
    Oncogene; 2002 May; 21(20):3199-206. PubMed ID: 12082635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced expression of Olig2 is sufficient for oligodendrocyte specification but not for motoneuron specification and astrocyte repression.
    Du ZW; Li XJ; Nguyen GD; Zhang SC
    Mol Cell Neurosci; 2006 Dec; 33(4):371-80. PubMed ID: 17035043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance.
    Tam CW; Chan KW; Liu VW; Pang B; Yao KM; Shiu SY
    J Pineal Res; 2008 Nov; 45(4):403-12. PubMed ID: 18637986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor signaling mediated by grb2 associated binder1 is required for the spatiotemporally regulated proliferation of olig2-expressing progenitors in the embryonic spinal cord.
    Hayakawa-Yano Y; Nishida K; Fukami S; Gotoh Y; Hirano T; Nakagawa T; Shimazaki T; Okano H
    Stem Cells; 2007 Jun; 25(6):1410-22. PubMed ID: 17332510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
    Jeon JH; Lee KN; Hwang CY; Kwon KS; You KH; Choi I
    Cancer Res; 2005 Jun; 65(11):4485-9. PubMed ID: 15930262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification.
    Mokhtari K; Paris S; Aguirre-Cruz L; Privat N; Crinière E; Marie Y; Hauw JJ; Kujas M; Rowitch D; Hoang-Xuan K; Delattre JY; Sanson M
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):62-9. PubMed ID: 15634232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
    Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
    Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that nucleocytoplasmic Olig2 translocation mediates brain-injury-induced differentiation of glial precursors to astrocytes.
    Magnus T; Coksaygan T; Korn T; Xue H; Arumugam TV; Mughal MR; Eckley DM; Tang SC; Detolla L; Rao MS; Cassiani-Ingoni R; Mattson MP
    J Neurosci Res; 2007 Aug; 85(10):2126-37. PubMed ID: 17510983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
    Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
    Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progression.
    Chassot AA; Turchi L; Virolle T; Fitsialos G; Batoz M; Deckert M; Dulic V; Meneguzzi G; Buscà R; Ponzio G
    Oncogene; 2007 Aug; 26(39):5772-83. PubMed ID: 17404577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.
    le Sage C; Nagel R; Egan DA; Schrier M; Mesman E; Mangiola A; Anile C; Maira G; Mercatelli N; Ciafrè SA; Farace MG; Agami R
    EMBO J; 2007 Aug; 26(15):3699-708. PubMed ID: 17627278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro differentiation of HT-29 M6 mucus-secreting colon cancer cells involves a trychostatin A and p27(KIP1)-inducible transcriptional program of gene expression.
    Mayo C; Lloreta J; Real FX; Mayol X
    J Cell Physiol; 2007 Jul; 212(1):42-50. PubMed ID: 17311291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.